Iopromide

Category: Diagnostic Aid



Iopromide Overview

Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.[1] It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs). Notes ^ The entry on Bayer Healthcare's website about Ultravist External links Bayer Schering Pharma global Ultravist Website vte...

Read more Iopromide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Iopromide

Recent Iopromide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Iopromide
  • Injection: 49.9%, 49.90%, 62.3%, 62.30%, 76.9%, 76.90%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Iopromide: (4 results)

Sorted by National Drug Code
  • 50419-340 Ultravist 311.7 mg/ml Intra-arterial; Intravenous Injection by Bayer Healthcare Pharmaceuticals Inc.
  • 50419-342 Ultravist 498.72 mg/ml Intra-arterial; Intravenous Injection by Bayer Healthcare Pharmaceuticals Inc.
  • 50419-344 Ultravist 623.4 mg/ml Intra-arterial; Intravenous Injection by Bayer Healthcare Pharmaceuticals Inc.
  • 50419-346 Ultravist 768.86 mg/ml Intra-arterial; Intravenous Injection by Bayer Healthcare Pharmaceuticals Inc.

Other drugs which contain Iopromide or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA